These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3711613)

  • 1. Treatment methods for extravasations of chemotherapeutic agents: a comparative study.
    Loth TS; Eversmann WW
    J Hand Surg Am; 1986 May; 11(3):388-96. PubMed ID: 3711613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidotes to vesicant chemotherapy extravasations.
    Dorr RT
    Blood Rev; 1990 Mar; 4(1):41-60. PubMed ID: 2182147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal surgical debridement for the treatment of chemotherapeutic agent-induced skin extravasations.
    Loth TS
    Cancer Treat Rep; 1986 Mar; 70(3):401-4. PubMed ID: 3955551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of extravasation in oncological care].
    Zatkóné Puskás G
    Magy Onkol; 2008 Mar; 52(1):75-80. PubMed ID: 18403301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extravasation of dactinomycin, vincristine, and cisplatin: studies in an animal model.
    Buchanan GR; Buchsbaum HJ; O'Banion K; Gojer B
    Med Pediatr Oncol; 1985; 13(6):375-80. PubMed ID: 4046975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options in extravasation injury: an experimental study in rats.
    Yilmaz M; Demirdover C; Mola F
    Plast Reconstr Surg; 2002 Jun; 109(7):2418-23. PubMed ID: 12045569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of growth factors on doxorubicin-induced skin necrosis: documentation of histomorphological alterations and early treatment by GM-CSF and G-CSF.
    Vargel I; Erdem A; Ertoy D; Pinar A; Erk Y; Altundag MK; Gullu I
    Ann Plast Surg; 2002 Dec; 49(6):646-53. PubMed ID: 12461449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing and managing vesicant chemotherapy extravasations.
    Schulmeister L
    J Support Oncol; 2010; 8(5):212-5. PubMed ID: 21086879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing vesicant extravasations.
    Schulmeister L
    Oncologist; 2008 Mar; 13(3):284-8. PubMed ID: 18378538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Oncology Nursing Society extravasation guidelines.
    Wengström Y; Margulies A;
    Eur J Oncol Nurs; 2008 Sep; 12(4):357-61. PubMed ID: 18765210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management after doxorubicin and epirubicin extravasation.
    Heitmann C; Durmus C; Ingianni G
    J Hand Surg Br; 1998 Oct; 23(5):666-8. PubMed ID: 9821616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: topical DMSO for mitomycin-C-induced skin ulceration.
    Alberts DS; Dorr RT
    Oncol Nurs Forum; 1991; 18(4):693-5. PubMed ID: 1906166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin ulceration potential of paclitaxel in a mouse skin model in vivo.
    Dorr RT; Snead K; Liddil JD
    Cancer; 1996 Jul; 78(1):152-6. PubMed ID: 8646711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous ulceration due to contrast extravasation. Experimental assessment of injury and potential antidotes.
    Elam EA; Dorr RT; Lagel KE; Pond GD
    Invest Radiol; 1991 Jan; 26(1):13-6. PubMed ID: 2022447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between subcutaneous steroid injection for extravasation of vesicant anticancer drugs and skin ulcers requiring surgery.
    Ohisa K; Yamana H; Morita K; Matsui H; Fushimi K; Yasunaga H
    Eur J Oncol Nurs; 2022 Jun; 58():102119. PubMed ID: 35358899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extravasation management.
    Schulmeister L
    Semin Oncol Nurs; 2007 Aug; 23(3):184-90. PubMed ID: 17693345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of adriamycin-induced full-thickness skin loss using hyaluronidase infiltration.
    Disa JJ; Chang RR; Mucci SJ; Goldberg NH
    Plast Reconstr Surg; 1998 Feb; 101(2):370-4. PubMed ID: 9462769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply to "Early subcutaneous wash-out in acute extravasations", by R. Giunta (Ann Oncol 2004; 15: 1146), and to the reply by D. Schrijvers (Ann Oncol 2004; 15: 1147).
    Chacon MR
    Ann Oncol; 2005 Jan; 16(1):170. PubMed ID: 15678595
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of antidotes for extravasation injury produced by 6-hydroxymethylacylfulvene (MGI 114), a novel cytotoxic antitumor agent, in an intradermal toxicity model in rats.
    Marshall RF; Arthaud LE; MacDonald JR
    Cancer Chemother Pharmacol; 2000; 45(5):397-401. PubMed ID: 10803923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extravasation of chemotherapeutic agents.
    Hankin FM; Louis DS
    Am Fam Physician; 1985 Mar; 31(3):147-50. PubMed ID: 3976457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.